magic mushrooms receives breakthrough status from the fda

Psilocybin Receives Breakthrough Status by the FDA for Depression

In November 2019, the US Food and Drug Administration (FDA) granted psilocybin therapy a breakthrough status for depression. This recognition makes it the second time in a year the FDA would designate such a status to psilocybin. The hallucinogenic compound in psychedelic mushrooms. The FDA’s action is meant to fast-track the typical slow process of […]

0
    0
    Your Cart
    Your cart is empty
      Calculate Shipping
      Apply Coupon